Gyre Therapeutics, Inc. (GYRE) Reports Q3 EPS of $0.01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts GYRE Hot Sheet
Join SI Premium – FREE
Gyre Therapeutics, Inc. (NASDAQ: GYRE) reported Q3 EPS of $0.01. Revenue for the quarter came in at $25.49 million, versus $0 reported last year.
For earnings history and earnings-related data on Gyre Therapeutics, Inc. (GYRE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Uber Q3 profit, revenue beat estimates as gross bookings jump 20%
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- LightPath Technologies to Host First Quarter Fiscal 2027 Earnings Call on November 10 at 5:00 p.m. Eastern Time
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
